Photo: FG Trade/Getty Images
AI safety and research company Anthropic announced the launch of Claude for Healthcare, a set of HIPAA-ready AI tools for providers, payers and patients. The offering builds on Anthropic's latest Claude model, Opus 4.5, which the company says delivers stronger performance on medical and scientific tasks and improved factual reliability.
The company says Claude for Healthcare can be used for prior authorizations and patient care coordination, and can help with regulatory submissions.
The offering also includes "connectors," which allow the AI to connect to the Centers for Medicare & Medicaid Services (CMS) Coverage Database, both local and national, to help with revenue cycle and compliance and to allow patient-facing teams to work with Medicare policy.
Users can also connect to the International Classification of Diseases, 10th Revision (ICD-10), to support medical coding, billing and claims management as well as the National Provider Identifier Registry, which helps with provider verification, credentialing networking directory management and claims validation.
Claude Pro and Max plan subscribers in the U.S. can also opt in to connect their personal health records to Claude to summarize records and explain results, but the company said there are explicit privacy controls and no data will be used for model training.
"In the US, Claude Pro and Max plan subscribers can choose to give Claude secure access to their lab results and health records. New HealthEx and Function connectors are available in beta today, while Apple Health and Android Health Connect integrations are rolling out in beta this week via the Claude iOS and Android apps," Anthropic said in a statement.
"When connected, Claude can summarize users’ medical history, explain test results in plain language, detect patterns across fitness and health metrics, and prepare questions for appointments. The aim is to make patients' conversations with doctors more productive, and to help users stay well-informed about their health."
Anthropic also announced the expansion of Claude's capabilities for the life sciences industry, including clinical trial operations and regulatory work.
"Claude now integrates with platforms like Medidata (trial data), ClinicalTrials.gov, bioRxiv/medRxiv (preprint research), Open Targets (drug targets), and others, helping with things like protocol drafting and trial planning," the company said.
"Existing scientific connectors (e.g., Benchling, PubMed, BioRender) remain supported and expanded, and new skills help automate bioinformatics and other research workflows."
Anthropic said Claude is the only frontier model available on AWS, Google Cloud and Microsoft, and the company is partnering with Accenture, Blank Metal, Caylent, Deloitte, Deepsense.ai, Firemind, KPMG, Provectus, PwC, OWT, Quantium, Slalom, Tribe AI and Turing to help organizations adopt AI for specialized work.
THE LARGER TREND
Last week, OpenAI announced the launch of ChatGPT Health, which will allow users to upload their personal medical records to ChatGPT to help them navigate their personal health journey and answer everyday questions.
The company also partnered with health management platform b.well to help ChatGPT Health users connect their personal medical records to the AI platform. OpenAI said b.well will serve as the technical back end to securely access and unify an individual's health data.
OpenAI said the new offering includes additional protections beyond ChatGPT, such as purpose-built encryption and isolation to protect and compartmentalize healthcare-related conversations, and said it would not use conversations within ChatGPT Health to train its foundation models.
Users can upload information, such as medical records for lab results, visit summaries and clinical history, as well as Apple Health data.
OpenAI said ChatGPT Health will initially be available to a small group of users to refine the experience, including users with ChatGPT Free, Go, Plus and Pro plans outside the European Economic Area, Switzerland and the UK, and select apps and medical record integrations are available in the U.S. only. The company plans to expand access to all users on the web and iOS in the coming weeks.
